US divided as voting with cards trumped by protesting with placards

Published 23-JAN-2017 14:15 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

While global markets were relatively measured despite the impact of Inauguration Day, the event couldn’t be viewed as one of reassurance.

At the top end of town, it was billionaire investor George Soros telling Bloomberg that uncertainty was at a peak and acknowledging his previous comments that a Trump victory was tantamount to electing a “would-be dictator”.

This reflected the mood in the streets as more than one million people, most waving placards that reflected their particular demographic or gender, turned out in protest.

One of Trump’s first ports of call after sign off was a meeting with the CIA where he publicly withdrew criticisms he levelled at his own intelligence agency earlier in the week. Arguably, a sound move given the degree of hatred reflected in the protests.

Consequently, it isn’t so much where markets finished last week but how they will be shaped by White House policy. It would appear from early signs that the Transpacific Partnership is dead in the water, and this was one of the key economic issues for Australia.

Japan and Canada are reportedly already looking for alternative strategies to facilitate trade, and issues regarding trade and foreign relations are shaping up as one of the key challenges facing the Turnbull government in 2017.

Looking at the raw numbers, the Dow and the NASDAQ finished up 0.5% and 0.3% respectively. In Europe, the FTSE 100 was down slightly after the release of the worst month on month retail sales figures in five years.

The Dax and the Paris CAC 40 were both up more than 0.2%.

Oil was the standout performer on the commodities front, gaining more than 2% as signs became evident that traction was starting to occur post the cuts in output.

Gold rallied from less than US$1200 per ounce to hit a high of US$1215 per ounce, but retraced late in trading to close at US$1210 per ounce.

Base metals continued trends that were evident throughout most of the week with nickel falling further, now down 10% from its thirty-day high of US$4.85 per pound to finish broadly in line with a four month low of US$4.36 per pound.

Copper was relatively flat, but there were good gains made by zinc and lead with both metals pushing up towards long-term highs.

The Australian dollar was relatively unmoved finishing just above US$0.75.

It should be noted that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X